VIM
PRCT icon

VELA Investment Management’s Procept Biorobotics PRCT Stock Holding History

VELA Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
113,722
+43,513
+62% +$1.09M 0.56% 63
2026
Q1 		$1.76M Buy
70,209
+33,387
+91% +$941K 0.41% 80
2025
Q4 		$1.16M Buy
+36,822
New +$1.22M 0.28% 108
2024
Q4 		– Sell
-19,616
Closed -$1.57M – 171
2024
Q3 		$1.57M Sell
19,616
-871
-4% -$61.9K 0.48% 75
2024
Q2 		$1.25M Hold
20,487
– – 0.39% 92
2024
Q1 		$1.01M Hold
20,487
– – 0.34% 98
2023
Q4 		$859K Buy
20,487
+2,757
+16% +$93.9K 0.33% 102
2023
Q3 		$582K Buy
+17,730
New +$604K 0.26% 102

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VELA Investment Management's PRCT Position: Q2 2026 in Review

VELA Investment Management increased its Procept Biorobotics (PRCT) stake by 62% in Q2 2026, buying an estimated $1.09M and bringing the position to 113,722 shares worth $2.57M. The position accounts for 0.56% of the portfolio, ranked #63.

VELA Investment Management first reported a position in PRCT in Q3 2023 and has held it in 8 quarters since. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • VELA Investment Management held 113,722 shares of Procept Biorobotics worth $2.57M as of Q2 2026.
  • VELA Investment Management bought 43,513 Procept Biorobotics shares in Q2 2026, an estimated $1.09M.
  • Procept Biorobotics made up 0.56% of VELA Investment Management's portfolio in Q2 2026, its #63 holding.
  • VELA Investment Management first reported a position in Procept Biorobotics in Q3 2023 and has held it in 8 quarters since.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on VELA Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.